Man Group
ECYT

Man Group’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Man Group’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-162,813
Closed -$2.89M – 2240
2018
Q3 		$2.89M Buy
+162,813
New +$2.8M 0.01% 1257

Other funds holding ECYT

OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
CA
Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Man Group's ECYT Position: Q4 2018 in Review

Man Group sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 162,813 shares — an estimated $2.89M sold.

Man Group first reported a position in ECYT in Q3 2018 and held it in 1 quarter. The position peaked at $2.89M in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

  • Man Group reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Man Group sold 162,813 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $2.89M.
  • Man Group first reported a position in Endocyte, Inc. Common Stock in Q3 2018 and held it in 1 quarter.
  • Man Group's Endocyte, Inc. Common Stock position peaked at $2.89M in Q3 2018.
  • 2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Man Group's 13F filing for Q4 2018, filed 14 Feb 2019.